Merit Medical Systems, Inc. (MMSI)
93.30
-0.64
(-0.68%)
USD |
NASDAQ |
Oct 23, 16:00
93.36
+0.06
(+0.06%)
Pre-Market: 20:00
Merit Medical Systems Enterprise Value : 5.940B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 5.940B |
| October 22, 2026 | 5.978B |
| October 21, 2026 | 5.827B |
| October 20, 2026 | 5.814B |
| October 19, 2026 | 5.741B |
| October 16, 2026 | 5.695B |
| October 15, 2026 | 5.717B |
| October 14, 2026 | 5.574B |
| October 13, 2026 | 5.632B |
| October 12, 2026 | 5.728B |
| October 09, 2026 | 5.577B |
| October 08, 2026 | 5.459B |
| October 07, 2026 | 5.450B |
| October 06, 2026 | 5.442B |
| October 05, 2026 | 5.572B |
| October 02, 2026 | 5.467B |
| October 01, 2026 | 5.513B |
| September 30, 2026 | 5.518B |
| September 29, 2026 | 5.616B |
| September 28, 2026 | 5.564B |
| September 25, 2026 | 5.594B |
| September 24, 2026 | 5.582B |
| September 23, 2026 | 5.568B |
| September 22, 2026 | 5.580B |
| September 21, 2026 | 5.474B |
| Date | Value |
|---|---|
| September 18, 2026 | 5.467B |
| September 17, 2026 | 5.479B |
| September 16, 2026 | 5.513B |
| September 15, 2026 | 5.515B |
| September 14, 2026 | 5.565B |
| September 11, 2026 | 5.526B |
| September 10, 2026 | 5.532B |
| September 09, 2026 | 5.575B |
| September 08, 2026 | 5.587B |
| September 04, 2026 | 5.719B |
| September 03, 2026 | 5.658B |
| September 02, 2026 | 5.751B |
| September 01, 2026 | 5.784B |
| August 31, 2026 | 5.783B |
| August 28, 2026 | 5.772B |
| August 27, 2026 | 5.716B |
| August 26, 2026 | 5.775B |
| August 25, 2026 | 5.808B |
| August 24, 2026 | 5.760B |
| August 21, 2026 | 5.790B |
| August 20, 2026 | 5.759B |
| August 19, 2026 | 5.861B |
| August 18, 2026 | 5.699B |
| August 17, 2026 | 5.727B |
| August 14, 2026 | 5.788B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 10.45B |
| Glaukos Corp. | 10.35B |
| Baxter International, Inc. | 19.76B |
| Becton, Dickinson & Co. | 70.12B |
| DexCom, Inc. | 28.87B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 38.80M |
| Revenue (Quarterly) | 419.49M |
| Total Expenses (Quarterly) | 380.68M |
| EPS Diluted (Quarterly) | 0.6466 |
| Gross Profit Margin (Quarterly) | 51.20% |
| Profit Margin (Quarterly) | 9.25% |
| Earnings Yield | 2.60% |
| Operating Earnings Yield | 3.58% |
| Normalized Earnings Yield | 2.657 |